Raise the issue of religious lobbying and the average American will immediately think of groups like the Moral Majority and the Christian Coalition, which enjoyed their heyday back in the 1980s and ’90s. But a new study by the Pew Forum on Religion and Public Life reveals that the number of religious — and anti-religious — groups pushing a plethora of values-based agendas has exploded over the past 40 years.
Catholics who believe the federal government should not be able to compel healthcare providers to perform abortions “have this conscience thing” that they really need to overcome, House Minority Leader Nancy Pelosi (D-Calif.) told the Washington Post recently. Otherwise, she said, women “could die” from a lack of access to abortion services.
A half dozen Republican candidates capitalized on their faith in an attempt to woo conservative voters in Iowa November 19, meeting with the faithful at an event entitled the Thanksgiving Family Forum (at left, candidates Ron Paul, Michelle Bachmann, Rick Santorum). Sponsored by a state organization called the Family Leader, with the help of Focus on the Family’s Citizen Link and the National Organization for Marriage, the event was “meant to mimic the holiday dinner, with six candidates — Michele Bachmann, Herman Cain, Newt Gingrich, Ron Paul, Rick Perry, and Rick Santorum — gathered around a table participating in a discussion moderated by [conservative pollster] Frank Luntz,” reported the Los Angeles Times. The Times identified the lead sponsor of the event as Bob Vander Plaats, “a three-time gubernatorial candidate [who] founded Family Leader to be a galvanizing force for social conservatives ahead of the state’s lead-off nominating caucuses.”
Four of MF Global’s former clients have made public their experiences with the failed financial derivatives broker, each of them losing their money and two of them their businesses as a result of MF Global’s bankruptcy.
Citing the uncertain economy and the scarcity of needed capital, the company that launched the first government funded embryonic stem-cell trials announced that it is halting further stem-cell research and will lay off nearly 40 percent of its staff. The California-based Geron Corp., which began the first FDA-approved stem-cell trials in 2010, said that it would shift its focus to cancer research.